Results 11 to 20 of about 233,415 (250)
Clinical and Translational Radiation Oncology, 2022 Background and purpose: The treatment of biochemical recurrence (BCR) after prostatectomy is challenging as the site of the recurrence is often undetectable.
Adalsteinn Gunnlaugsson +10 more
doaj +1 more source
The diagnostic value of a new formula combining age and prostate volume in prostate cancer
Journal of Men's Health, 2022 Background and objective: This study combined two clinical indicators (age and prostate volume (PV)) to generate age to PV (AVR) ratio, whose diagnostic value for prostate cancer (PCa) was examined based on prostate specific antigen (PSA) in the range
Xiaobo Yang +8 more
doaj +1 more source
PROSTATE-SPECIFIC ANTIGEN VELOCITY AND REPEATED MEASURES OF PROSTATE-SPECIFIC ANTIGEN
Urologic Clinics of North America, 1997 Numerous studies evaluating different populations have shown similar findings with respect to repeated PSA measurements and PSAV. First, there is substantial within-individual variability between repeated PSA measures. Second, this variability between PSA measurements precludes the use of a simple change in PSA as a marker for prostate cancer.
H B, Carter, J D, Pearson
openaire +2 more sources
Journal of Experimental & Clinical Cancer Research, 2010 Background The present study was undertaken to relate the co-expression of prostate-associated antigens, PSMA and PSA, with the degree of vascularization in normal and pathologic (hyperplasia and cancer) prostate tissues to elucidate their possible role ...
Nouira Yassin +8 more
doaj +1 more source
The effects of specific expression of apoptin under the control of PSES and PSA promoter on cell death and apoptosis of LNCaP cells [PDF]
Iranian Journal of Basic Medical Sciences, 2017 Objective(s): Apoptotic effect of apoptin has been demonstrated in numerous studies. However, its tumor specificity has been questioned by some reports.
Vida Mohammadi +6 more
doaj +1 more source
Evaluation of Prostate specific antigen levels and its correlation with histopathological findings
Journal of Pathology of Nepal, 2019 Background: Prostate specific antigen is a tumor marker though is expressed by both normal and neoplastic prostate tissue. The absolute value of Prostate specific antigen is useful for determining the extent of prostate cancer and its treatment. Prostate
Sujata Pudasaini +2 more
doaj +1 more source
Indian Journal of Urology, 2007 Introduction: We sought to determine the distribution of serum prostate specific antigen (PSA) levels in a community-based population in the state of Gujarat in India.
Arvind P Ganpule +3 more
doaj +1 more source
The Western journal of medicine, 1992 The Scientific Board of the California Medical Association presents the following inventory of items of progress in urology. Each item, in the judgment of a panel of knowledgeable physicians, has recently become reasonably firmly established, both as to scientific fact and important clinical significance.
+7 more sources
Prostate-Specific Antigen in Prostate Cancer
The International Journal of Biological Markers, 1986 Prostate-specific antigen (PA) has been evaluated clinically as a tumor marker of prostate cancer with the use of enzyme immunoassay (EIA). For serodetection of prostate cancer, PA was assayed in a total of 1,109 sera. From mean ± 3 S.D.
Manabu Kuriyama
doaj +1 more source
Asian Journal of Andrology, 2014 To clarify the recent trends in prostate-specific antigen (PSA) distribution in men in Japan, we analyzed the PSA distributions of men undergoing PSA-based population screening.
Yasuhide Kitagawa +10 more
doaj +1 more source